Xiaoyan Jiang Selected Research

2 Atopic Dermatitis

11/2017

Cimifugin suppresses allergic inflammation by reducing epithelial derived initiative key factors via regulating tight junctions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyan Jiang Research Topics

Disease

29	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2021 - 11/2002
26	Neoplasms (Cancer) 12/2021 - 04/2002
16	Leukemia 10/2019 - 05/2002
9	Inflammation (Inflammations) 10/2019 - 04/2006
8	Myopia 12/2020 - 02/2017
7	Stroke (Strokes) 01/2021 - 12/2016
6	Brain Injuries (Brain Injury) 01/2021 - 01/2016
4	Hypoxia (Hypoxemia) 01/2022 - 07/2017
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2011
4	Triple Negative Breast Neoplasms 01/2021 - 01/2019
4	Ischemic Stroke 01/2019 - 12/2016
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2021 - 06/2020
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 01/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2012
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2017 - 12/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 04/2002
2	Wounds and Injuries (Trauma) 01/2021 - 01/2020
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 10/2020
2	Ulcer 01/2020 - 01/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2019 - 07/2017
2	Carcinoma (Carcinomatosis) 10/2019 - 01/2017
2	Lung Injury 05/2019 - 02/2018
2	Infections 05/2019 - 01/2019
2	Adenocarcinoma 01/2019 - 01/2011
2	Type 2 Diabetes Mellitus (MODY) 01/2019 - 12/2014
2	Chronic Hepatitis B 01/2019 - 12/2018
2	Brain Ischemia (Cerebral Ischemia) 08/2017 - 12/2016
2	Disease Progression 07/2017 - 06/2014
2	Brain Diseases (Brain Disorder) 12/2016 - 12/2011
1	Late-Onset Retinal Degeneration 01/2022
1	Ganglion Cysts (Ganglion) 01/2022
1	Familial Exudative Vitreoretinopathies 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Carcinogenesis 12/2021
1	Hypoadiponectinemia 10/2021
1	Neuroinflammatory Diseases 10/2021
1	Dementia (Dementias) 10/2021
1	Carotid Stenosis (Carotid Artery Stenosis) 10/2021
1	Heterotopic Ossification (Ectopic Ossification) 05/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2003
12	Tyrosine Kinase InhibitorsIBA 01/2020 - 10/2008
11	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
10	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2012
10	Imatinib Mesylate (Gleevec)FDA Link 01/2019 - 01/2006
8	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2015
5	Phosphotransferases (Kinase)IBA 01/2021 - 05/2002
5	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2019 - 12/2016
5	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019 - 01/2016
3	Retinaldehyde (Retinal)IBA 01/2022 - 08/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2017
3	Cadherins (E-Cadherin)IBA 01/2022 - 01/2017
3	PolyethyleneimineIBA 11/2021 - 01/2012
3	LipidsIBA 01/2021 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2008
3	trans-sodium crocetinate (crocetin)IBA 01/2020 - 01/2019
3	Messenger RNA (mRNA)IBA 10/2019 - 06/2014
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2006 - 11/2002
2	Mitogen-Activated Protein KinasesIBA 01/2022 - 10/2019
2	Biological ProductsIBA 01/2022 - 01/2020
2	Estrogens (Estrogen)FDA Link 12/2021 - 07/2017
2	CateninsIBA 12/2021 - 08/2020
2	CholesterolIBA 11/2021 - 01/2020
2	PolymersIBA 11/2021 - 12/2013
2	Autocrine Motility Factor ReceptorsIBA 01/2021 - 01/2019
2	platelet protein P47 (pleckstrin)IBA 01/2021 - 01/2019
2	Caspase 3 (Caspase-3)IBA 01/2021 - 10/2019
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2021 - 06/2020
2	Antiviral Agents (Antivirals)IBA 01/2021 - 05/2019
2	Adenosine Triphosphate (ATP)IBA 06/2020 - 01/2011
2	Carotenoids (Carotene)IBA 01/2020 - 08/2019
2	MicroRNAs (MicroRNA)IBA 01/2020 - 07/2019
2	Oxygen (Dioxygen)IBA 11/2019 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2019 - 05/2015
2	Lamivudine (Epivir)FDA Link 01/2019 - 10/2018
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2019 - 05/2009
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 09/2010
2	NF-kappa B (NF-kB)IBA 02/2018 - 12/2014
2	Fish OilsIBA 10/2017 - 12/2016
2	diallyl trisulfideIBA 07/2017 - 01/2017
2	Docosahexaenoic AcidsIBA 12/2016 - 12/2016
2	scriptaidIBA 03/2015 - 01/2013
1	p21-Activated KinasesIBA 01/2022
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	6-methyladenineIBA 01/2022
1	NAD (NADH)IBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Estrogen ReceptorsIBA 12/2021
1	Oncogene Proteins (Oncogene Protein)IBA 12/2021
1	Adiponectin ReceptorsIBA 10/2021
1	AdiponectinIBA 10/2021
1	AdipoRonIBA 10/2021

Therapy/Procedure

36	Therapeutics 01/2022 - 04/2002
4	Drug Therapy (Chemotherapy) 10/2020 - 11/2014
4	Injections 01/2019 - 04/2006
2	Surgical Amputation (Amputations) 01/2021 - 01/2019
2	Limb Salvage 01/2020 - 01/2019
2	Lenses 01/2019 - 01/2018
1	X-Ray Film 05/2021